11 results  1 of 1 

1 Peroxisomal Fitness: A Potential Protective Mechanism of Fenofibrate against High Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice
Songling Jiang, Md Jamal Uddin, Xiaoying Yu, Lingjuan Piao, Debra Dorotea, Goo Taeg Oh, Hunjoo Ha
Diabetes Metab J.2022;46(6):829-842.   Published online 2022 June 24     DOI: http://dx.doi.org/10.4093/dmj.2021.0274
      
2 Effects of Switching from Fenofibrate to Pemafibrate for Asymptomatic Primary Biliary Cholangitis
Kazufumi Dohmen, Shin-ya Onohara, Shigeru Harada
Korean J Gastroenterol.2021;78(4):227-234.   Published online 2021 October 25     DOI: http://dx.doi.org/10.4166/kjg.2021.092
      
3 Neither polyphenol-rich red wine nor fenofibrate affects the onset of type-1 diabetes mellitus in the BB rat
Karin Åvall, Per-Olof Berggren, Lisa Juntti-Berggren
Lab Anim Res.2018;34(3):126-131.   Published online 2018 September 27     DOI: http://dx.doi.org/10.5625/lar.2018.34.3.126
      
4 Effect of Long-term Fenofibrate Therapy on Serum Creatinine and Its Reversibility in Hypertriglyceridemic Patients with Hypertension
Gyu Tae Park, Moonki Jung, Young Kim, Iksung Cho, Hoyoun Won, Seung Yong Shin, Wang-Soo Lee, Kwang Je Lee, Sang-Wook Kim, Tae Ho Kim, Chee Jeong Kim
J Lipid Atheroscler.2017;6(2):89-96.   Published online 2017 December 31     DOI: http://dx.doi.org/10.12997/jla.2017.6.2.89
      
5 Effect of Fenofibrate Therapy on Blood Creatinine Levels in Patients with Hypertension and Hypertriglyceridemia
Jun Hwan Cho, Young Hwan Choi, Cheol Won Hyeon, Kyung Joon Kim, Seonghyup Hyun, Jee Eun Kwon, Eun Young Kim, Wang-Soo Lee, Kwang Je Lee, Sang-Wook Kim, Tae Ho Kim, Chee Jeong Kim
J Lipid Atheroscler.2013;2(1):19-26.   Published online 2013 May 15     DOI: http://dx.doi.org/10.12997/jla.2013.2.1.19
      
6 Reduction of Food Intake by Fenofibrate is Associated with Cholecystokinin Release in Long-Evans Tokushima Rats
Mi-Kyoung Park, Ying Han, Mi Sun Kim, Eunhui Seo, Soojeong Kang, So-Young Park, Hyeongjong Koh, Duk Kyu Kim, Hye-Jeong Lee
Korean J Physiol Pharmacol.2012;16(3):181-186.   Published online 2012 June 26     DOI: http://dx.doi.org/10.4196/kjpp.2012.16.3.181
      
7 Activation of PPARα Attenuates IFNγ and IL-1β-induced Cell Proliferation in Astrocytes: Involvement of IL-6 Independent Pathway
Jin-Koo Lee, Eun-Min Seo, Sang-Soo Lee, Soo-Hyun Park, Yun-Beom Sim, Jun-Sub Jung, Seon-Mi Kim, Hong-Won Suh
Korean J Physiol Pharmacol.2010;14(3):185-189.   Published online 2010 February 18     DOI: http://dx.doi.org/10.4196/kjpp.2010.14.3.185
   
8 Fenofibrate Reduces Age-related Hypercholesterolemia in Normal Rats on a Standard Diet
Ying Han, Mi-Hyang Do, Mi Sun Kim, Eunhui Seo, Mi-Kyoung Park, Duk Kyu Kim, Hye-Jeong Lee, Su-Yeong Seo
Korean J Physiol Pharmacol.2010;14(2):77-81.   Published online 2010 February 18     DOI: http://dx.doi.org/10.4196/kjpp.2010.14.2.77
   
9 HDL Cholesterol Reduction during Rosiglitazone and Fenofibrate Treatment in a Type 2 Diabetes Mellitus Patient with Dyslipidemia
Mijeong Im, Minki Kim, Jin Kyung Lee, Yoon Hwan Chang, Dong Young Lee, Seok-Il Hong, Yun Yong Lee, Young Jun Hong
Korean J Lab Med.2010;30(1):17-19.   Published online 2010 January 14     DOI: http://dx.doi.org/10.3343/kjlm.2010.30.1.17
   
10 The Effect of Fenofibrate and Exercise on Metabolic Syndrome and Hepatic Steatosis in OLETF Rats
Kyung-II Lee, Ji Min Kim, Ja Young Park, Ja Won Kim, Ji Young Mok, Mi-Kyoung Park, Hye-Jeong Lee, Sook Hee Hong, Wenjun Li, Duk Kyu Kim
J Korean Endocr Soc.2007;22(3):192-202.   Published online 2007 June 20     DOI: http://dx.doi.org/10.3803/jkes.2007.22.3.192
      
11 The Increase in Hepatic Uncoupling by Fenofibrate Contributes to a Decrease in Adipose Tissue in Obese Rats
Mi-Kyoung Park, Hye-Jeong Lee, Sook-Hee Hong, Sun-Seob Choi, Young Hyun Yoo, Kyung Il Lee, Duk Kyu Kim
J Korean Med Sci.2007;22(2):235-241.   Published online 2007 April 30     DOI: http://dx.doi.org/10.3346/jkms.2007.22.2.235
      

 1 of 1